英文简介：

Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy''s 2015 impact factor is 6.938. Molecular Therapy — Oncolytics Molecular Therapy—Oncolytics is an international, online-only, open-access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. While providing a unique forum for work in the burgeoning fields of oncolytic virotherapy, as well as T cell- and stem cell-based therapies, the journal will consider all top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination, or transfer of cells and/or genes. As an official journal of the American Society of Gene & Cell Therapy, Molecular Therapy—Oncolytics will build upon the success of Molecular Therapy and its sibling journals in publishing important peer-reviewed original research and editorial commentary.

中文简介：（来自Google、百度翻译）

分子治疗 《分子疗法》杂志是基因转移、载体开发与设计、干细胞操作、基因、肽、蛋白、寡核苷酸的开发、细胞疗法、疫苗开发、临床前目标验证、安全性/有效性研究和临床试验等领域的领先期刊。分子疗法致力于促进遗传学、医学和生物技术的科学发展。出版重要的同行评审研究和前沿评论和评论，该杂志继续吸引该领域的最佳材料。分子治疗2015年影响因子为6.938。 分子疗法-溶瘤疗法 《分子治疗- oncolytics》是一本国际性的、在线的、开放获取的杂志，专注于针对癌症的病毒、细胞和其他生物疗法的开发和临床测试。同时提供一个独特的论坛在新兴领域的溶瘤病毒治疗工作,以及T细胞,干细胞疗法,《华尔街日报》将考虑所有优质,尖端研究,采用创新的分子和细胞的方法,目标肿瘤细胞破坏,是否由病毒、其他微生物,免疫接种,或转移的细胞和/或基因。作为美国基因与细胞治疗学会的官方期刊，分子治疗-溶瘤学将建立在分子治疗及其兄弟期刊的成功基础上，发表重要的同行评审的原始研究和编辑评论。